Thrivent Financial For Lutherans Argenx Se Transaction History

Thrivent Financial For Lutherans

  • $52.6 Billion
  • Q3 2024

A detailed history of Thrivent Financial For Lutherans transactions in Argenx Se stock. As of the latest transaction made, Thrivent Financial For Lutherans holds 37,352 shares of ARGX stock, worth $23.8 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares
37,352
Previous 36,788 1.53%
Holding current value
$23.8 Million
Previous $15.8 Million 27.99%
% of portfolio
0.04%
Previous 0.03%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 07, 2024
BUY
$434.22 - $551.9 $244,900 - $311,271
564 Added 1.53%
37,352 $20.2 Million
Q2 2024

Aug 13, 2024
SELL
$356.01 - $451.55 $1.92 Million - $2.43 Million
-5,384 Reduced 12.77%
36,788 $15.8 Million
Q1 2024

May 14, 2024
SELL
$356.95 - $413.29 $7.04 Million - $8.15 Million
-19,711 Reduced 31.85%
42,172 $16.6 Million
Q4 2023

Feb 14, 2024
SELL
$338.91 - $506.01 $2.43 Million - $3.63 Million
-7,183 Reduced 10.4%
61,883 $23.5 Million
Q3 2023

Nov 14, 2023
BUY
$369.35 - $548.43 $319,857 - $474,940
866 Added 1.27%
69,066 $34 Million
Q2 2023

Aug 14, 2023
SELL
$360.14 - $422.58 $3.23 Million - $3.79 Million
-8,957 Reduced 11.61%
68,200 $26.6 Million
Q1 2023

May 17, 2023
BUY
$334.23 - $403.65 $348,936 - $421,410
1,044 Added 1.37%
77,157 $28.7 Million
Q4 2022

Feb 08, 2023
SELL
$342.17 - $402.31 $199,827 - $234,949
-584 Reduced 0.76%
76,113 $28.8 Million
Q3 2022

Nov 14, 2022
SELL
$343.2 - $395.75 $372,372 - $429,388
-1,085 Reduced 1.39%
76,697 $27.1 Million
Q2 2022

Aug 16, 2022
SELL
$269.58 - $378.88 $1.25 Million - $1.75 Million
-4,623 Reduced 5.61%
77,782 $29.5 Million
Q1 2022

May 13, 2022
BUY
$254.45 - $351.06 $1.21 Million - $1.67 Million
4,745 Added 6.11%
82,405 $26 Million
Q4 2021

Feb 16, 2022
BUY
$272.01 - $353.03 $3.59 Million - $4.65 Million
13,183 Added 20.45%
77,660 $27.2 Million
Q3 2021

Nov 15, 2021
SELL
$295.0 - $350.58 $7.07 Million - $8.4 Million
-23,959 Reduced 27.09%
64,477 $19.5 Million
Q2 2021

Aug 19, 2021
BUY
$257.11 - $319.92 $202,859 - $252,416
789 Added 0.9%
88,436 $26.6 Million
Q1 2021

May 17, 2021
SELL
$268.3 - $380.31 $1.92 Million - $2.73 Million
-7,168 Reduced 7.56%
87,647 $24.1 Million
Q4 2020

Feb 16, 2021
BUY
$248.13 - $308.36 $2.9 Million - $3.6 Million
11,682 Added 14.05%
94,815 $27.9 Million
Q3 2020

Nov 10, 2020
BUY
$215.51 - $272.51 $11.4 Million - $14.4 Million
52,904 Added 175.01%
83,133 $21.8 Million
Q2 2020

Aug 12, 2020
BUY
$127.44 - $232.72 $898,324 - $1.64 Million
7,049 Added 30.41%
30,229 $6.81 Million
Q1 2020

May 15, 2020
BUY
$108.83 - $165.23 $2.52 Million - $3.83 Million
23,180 New
23,180 $3.05 Million

Others Institutions Holding ARGX

# of Institutions
401
Shares Held
30.9M
Call Options Held
376K
Put Options Held
489K
View Full List

About ARGENX SE

ARGX Quotes by TradingView
  • Ticker ARGX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 55,323,800
  • Market Cap $35.3B
  • Description
  • argenx SE, a biotechnology company, focuses on developing various therapies for the treatment of autoimmune diseases in the United States, the Netherlands, Belgium, Japan, Switzerland, Germany and France. Its lead product candidate is efgartigimod for the treatment of patients with myasthenia gravis, immune thrombocytopenia, pemphigus vulgaris, ...
More about ARGX
Track This Portfolio

Track Thrivent Financial For Lutherans Portfolio

Follow Thrivent Financial For Lutherans and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Thrivent Financial For Lutherans, based on Form 13F filings with the SEC.

News

Stay updated on Thrivent Financial For Lutherans with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email